Quote For K-V Pharmaceutical Company KVb.N
K-V Pharmaceutical Company (KVb.N) (New York Stock Exchange)
sector: Healthcare ·
industry: Pharmaceuticals - Generic & Specialty ·
$4.07
27 Nov 2009
-0.49%
$4.09
$4.10
1,100
$4.10
$4.07
$8.43
$0.43
2.37
3,388
News
No news stories for this company within the last 30 days.
Press Releases
No news stories for this company within the last 30 days.
Key Developments
Officers
| Name | Current Position | Compensation |
|---|---|---|
| Hatfield, Terry | Non-Executive Chairman of the Board | -- |
| Van Vliet, David | Interim Chief Executive Officer; President and Chief Executive Officer of ETHEX Corporation | 641,480 |
| McHugh, Thomas | Interim Chief Financial Officer, Vice President - Finance, Controller | -- |
Key Ratios and Statistics
| Share Related Items | |
|---|---|
| Market Cap (Mil.) | $169.32 |
| Shares Outstanding (Mil.) | 49.95 |
| Float (Mil.) | 37.20 |
| Dividend Information | |
|---|---|
| Yield % | -99,999.99 |
| Annual Dividend ($ USD) | 0.00 |
| Payout Ratio(TTM) % | 0.00 |
| Financial Strength | |
|---|---|
| Quick Ratio | 0.98 |
| Current Ratio | 5.37 |
| LT Debt/Equity | 57.39 |
| Total Debt/Equity | 57.83 |
| Valuation Ratios | |
|---|---|
| Price/Earnings(TTM) | 2.07 |
| Price/Sales(TTM) | 0.27 |
| Price/Book(TTM) | 0.36 |
| Price/Cash Flow(TTM) | 1.32 |
| Per Share Data | |
|---|---|
| Earnings(TTM) | $1.92 |
| Sales(TTM) | $8.92 |
| Book Value(MRQ) | $9.38 |
| Cash Flow(TTM) | $1.80 |
| Cash(MRQ) | $2.72 |
| Management Effectiveness | |
|---|---|
| Return on Equity(TTM) | 22.58 |
| Return on Assets(TTM) | 11.88 |
| Return on Investment(TTM) | 14.86 |
| Margins | |
|---|---|
| Gross Margin(TTM) % | 69.80 |
| Operating Margin(TTM) % | 22.35 |
| Profit Margin(TTM) % | 14.88 |
Market Update
UK
US- Europe
- Asia
- UK Most Actives
advertisement
